Copyright
©The Author(s) 2024.
World J Gastrointest Surg. Jun 27, 2024; 16(6): 1629-1636
Published online Jun 27, 2024. doi: 10.4240/wjgs.v16.i6.1629
Published online Jun 27, 2024. doi: 10.4240/wjgs.v16.i6.1629
Table 2 Demographic factors and their relationship with survival
Univariate analysis - factors associated with survival | ||
Demographic factors | Hazard ratio | P value |
Age | 1.003 (0.99-1.02) | |
Male | 0.93 (0.63-1.38) | |
Smoker | 1.12 (0.63-1.98) | |
European | 1.24 (0.84-1.84) | |
Asian | 0.45 (0.24-0.84) | 0.013 |
Pacific Peoples | 0.92 (0.50-1.69) | |
Māori | 1.35 (0.78-2.34) | |
MELAA | 11.3 (2.62-48.64) | 0.001 |
Unknown | 0.66 (0.16-2.76) | |
Surgery | 0.20 (0.13-0.30) | < 0.001 |
Stage IV | 5.13 (3.35-7.87) | < 0.001 |
Stage (overall) | 2.23 (1.78-2.79) | < 0.001 |
Charlson Comorbidity Index | 1.27 (1.18-1.38) | < 0.001 |
Proportion of signet ring cells | 1.07 (0.72-1.58) | |
Neoadjuvant chemotherapy | 1.87 (0.93-3.76) | |
Multivariate analysis - factors associated with survival | ||
Stage | 1.62 (1.30-2.01) | < 0.001 |
Surgery | 0.27 (0.17-0.42) | < 0.001 |
Charlson Comorbidity Index | 1.19 (1.08-1.30) | < 0.001 |
Asian ethnicity | 0.75 (0.39-1.43) |
- Citation: Grinlinton M, Furkert C, Maurice A, Angelo N, Booth M. Gastroesophageal signet ring cell carcinoma morbidity and mortality: A retrospective review. World J Gastrointest Surg 2024; 16(6): 1629-1636
- URL: https://www.wjgnet.com/1948-9366/full/v16/i6/1629.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v16.i6.1629